Skip to main content
. 2016 Jan 12;3:153–159. doi: 10.1016/j.toxrep.2016.01.006

Fig. 1.

Fig. 1

Cell viability of hPTCs and HEK293 cells after exposure to 50 or 80 μM cisplatin. (A). hPTC viability after 12, 24 or 48 h incubation with 50 or 80 μM cisplatin compared to vehicle control (DMSO). (B). HEK293 viability after 12, 24 h or 48 h incubation with 50 or 80 μM cisplatin compared to vehicle control (DMSO). Data are means ± SEM. (n = 4-6). *p < 0.05 compared to vehicle control (DMSO).